| Source: |
| Type: |
| Autophagy Regulator: – ATG7 is an E1-like enzyme crucial for the autophagy pathway. – It participates in the conjugation systems that drive autophagosome formation (e.g., ATG12–ATG5 and LC3 lipidation systems). • Elevated Expression: – In certain cancers (e.g., pancreatic cancer, some subtypes of breast cancer), ATG7 can be upregulated. – Increased ATG7 expression in some contexts is thought to help tumors survive under metabolic stress by enhancing autophagy. • Reduced Expression or Loss-of-Function: – In other contexts – for instance, in some liver cancers or specific lung cancers – reduced expression or inactivation of ATG7 has been reported. – This reduction might lead to failure of effective autophagy in tumor-suppressive contexts. |
| Pancreatic Cancer: Hypoxia (low oxygen tension) is commonly found in solid tumors. Hypoxia-inducible factor-1 (HIF-1),is a key mediator of the cellular response to hypoxia and is overexpressed in a wide variety of solid tumors, including pancreatic cancer. Nanog is highly expressed in CSCs compared to normal cells [93–97] HIF-1↑ |
| 1580- | Citrate, | Citrate activates autophagic death of prostate cancer cells via downregulation CaMKII/AKT/mTOR pathway |
| - | in-vitro, | Pca, | PC3 | - | in-vivo, | PC, | NA | - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | WPMY-1 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:21 Cells:% prod#:% Target#:986 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid